MORC3
Basic information
Region (hg38): 21:36320189-36386148
Previous symbols: [ "ZCWCC3" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MORC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 37 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 4 | 1 |
Variants in MORC3
This is a list of pathogenic ClinVar variants found in the MORC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-36320283-C-G | not specified | Uncertain significance (Sep 29, 2022) | ||
21-36333715-A-G | not specified | Uncertain significance (Feb 28, 2024) | ||
21-36336940-A-G | not specified | Uncertain significance (Oct 10, 2023) | ||
21-36337769-G-A | not specified | Uncertain significance (Jan 12, 2024) | ||
21-36337829-G-T | not specified | Uncertain significance (Dec 19, 2022) | ||
21-36337871-C-G | not specified | Uncertain significance (Sep 14, 2022) | ||
21-36337938-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
21-36338842-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
21-36344918-A-G | not specified | Uncertain significance (Jan 20, 2023) | ||
21-36359959-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
21-36360024-G-A | not specified | Likely benign (Oct 03, 2022) | ||
21-36360030-A-G | Likely benign (May 01, 2023) | |||
21-36360188-T-G | not specified | Uncertain significance (Apr 07, 2022) | ||
21-36360218-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
21-36364157-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
21-36364174-C-T | not specified | Uncertain significance (May 17, 2023) | ||
21-36364175-A-G | not specified | Uncertain significance (May 23, 2023) | ||
21-36364217-A-C | not specified | Uncertain significance (May 05, 2023) | ||
21-36364235-C-A | not specified | Uncertain significance (May 02, 2024) | ||
21-36368988-C-G | not specified | Uncertain significance (May 03, 2023) | ||
21-36369010-C-T | not specified | Uncertain significance (May 17, 2023) | ||
21-36369052-C-G | not specified | Uncertain significance (Jan 18, 2023) | ||
21-36369174-C-A | not specified | Uncertain significance (May 13, 2024) | ||
21-36369175-G-A | not specified | Likely benign (Mar 08, 2024) | ||
21-36369221-C-G | not specified | Uncertain significance (Jan 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MORC3 | protein_coding | protein_coding | ENST00000400485 | 17 | 65960 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000155 | 124780 | 0 | 14 | 124794 | 0.0000561 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.89 | 320 | 502 | 0.637 | 0.0000262 | 6272 |
Missense in Polyphen | 48 | 183.72 | 0.26127 | 2338 | ||
Synonymous | 0.0374 | 177 | 178 | 0.996 | 0.0000100 | 1655 |
Loss of Function | 5.68 | 5 | 47.1 | 0.106 | 0.00000241 | 594 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000159 | 0.000159 |
Ashkenazi Jewish | 0.0000999 | 0.0000993 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.0000628 | 0.0000618 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.000166 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Nuclear factor which forms MORC3-NBs (nuclear bodies) via an ATP-dependent mechanism (PubMed:20501696). Sumoylated MORC3-NBs can also associate with PML-NBs (PubMed:20501696). Recruits TP53 and SP100 to PML-NBs, thus regulating TP53 activity (PubMed:17332504). Binds RNA in vitro (PubMed:11927593). May be required for influenza A transcription during viral infection (PubMed:26202233). {ECO:0000269|PubMed:11927593, ECO:0000269|PubMed:17332504, ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:26202233}.;
- Pathway
- Interactome of polycomb repressive complex 2 (PRC2)
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.202
- rvis_EVS
- -0.71
- rvis_percentile_EVS
- 14.57
Haploinsufficiency Scores
- pHI
- 0.589
- hipred
- Y
- hipred_score
- 0.717
- ghis
- 0.624
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.420
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Morc3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein phosphorylation;cell aging;post-embryonic development;viral process;peptidyl-serine phosphorylation;negative regulation of fibroblast proliferation;protein stabilization;maintenance of protein location in nucleus
- Cellular component
- nucleoplasm;nuclear matrix;PML body
- Molecular function
- RNA binding;zinc ion binding